SIGA Technologies Inc. Approved for NASDAQ Global Market Listing
NEW YORK, Sept. 3, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies Inc. (Nasdaq:SIGA - News) announced today that its common stock listing will transfer from the NASDAQ Capital Market to the NASDAQ Global Market. The transfer will be effective at the opening of business on Thursday, September 3, 2009 and the Company's common stock will continue to trade under the symbol "SIGA".
Commenting on the move, Dr. Eric Rose, SIGA's Chief Executive Officer, said, "The transfer of SIGA's stock to the NASDAQ Global Market reflects SIGA's growth over the past year. We believe that the transfer to the Global Market will provide our investors with expanded liquidity for their SIGA stock."
About SIGA Technologies, Inc.
SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential bio-warfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA's web site at siga.com. |
